NGFR and neoplasm: Overexpression of p75NTR has been associated with advanced stages of melanoma progression, but a small molecule was able to inhibit tumor growth in a mouse model by targeting the TMD of p75NTR to disrupt oligomerization and downstream signaling of this receptor [172].